The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Verbovoĭ A.F.

Kafedra éndokrinologii Samarskogo gosudarstvennogo meditsinskogo universiteta

Pashentseva A.V.

Samara State Medical University, Ministry of Health of Russia, Samara, Russia

Sharonova L.A.

Samara State Medical University, Health Ministry of Russia, Samara, Russia

Osteoporosis: Current state of the art

Authors:

Verbovoĭ A.F., Pashentseva A.V., Sharonova L.A.

More about the authors

Journal: Therapeutic Archive. 2017;89(5): 90‑97

DOI: 10.17116/terarkh201789590-97

Read: 48369 times

Download PDF (RU)
Contact the author
Table of contents

OSTEOPOROSIS: CURRENT STATE OF THE ART
OSTEOPOROSIS: CURRENT STATE OF THE ART

To cite this article:

Verbovoĭ AF, Pashentseva AV, Sharonova LA. Osteoporosis: Current state of the art. Therapeutic Archive. 2017;89(5):90‑97. (In Russ.)
https://doi.org/10.17116/terarkh201789590-97

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Risk factors asso­ciated with myopic macu­lopathy in acquired myopia. Russian Annals of Ophthalmology. 2024;(5):35-45
Epidemiology of suicidal beha­vior in children and adolescents worldwide. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11-2):16-26
Rationale for the use of non-linear statistical methods in the analysis of rela­tionships between risk factors and fatal events acco­rding to the data of long-term prospective obse­rvation in popu­lation of Russia and the United States of America. Russian Journal of Preventive Medi­cine. 2024;(11):34-39
Features of como­rbidity pathology in young people. Russian Journal of Preventive Medi­cine. 2024;(11):63-69
Comparison of models for prediction of spontaneous preterm birth. Medi­cal Technologies. Asse­ssment and Choice. 2024;(4):10-19
Liver and bone in tandem: osteopenia as an inevitable companion to non-alcoholic fatty liver disease. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):40-50
Stru­ctural and functional features of the main arte­ries of the brain and tumor necrosis factor-alpha in people with chro­nic non-infectious diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):178-184
Clinical and epidemiological characteristics of myasthenia in the Altai region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):198-202
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139
The resu­lts of a 5-year clinical and epidemiological study of the National Program “Chronic tonsillitis”. Russian Bulletin of Otorhinolaryngology. 2024;(6):28-39
Abstract:

As of now, osteoporosis (OP) is one of the most important sociomedical problems because of its high prevalence and resultant disability, as well as significant mortality attributable to complications. The current strategy for providing care for patients of OP is its early diagnosis, by determining the high risk of fractures, and early pathogenetic treatment. The article gives an update on the epidemiology, risk factors, diagnosis, and treatment of OP.

Keywords:

osteoporosis
epidemiology
risk factors
treatment of osteoporosis

Authors:

Verbovoĭ A.F.

Kafedra éndokrinologii Samarskogo gosudarstvennogo meditsinskogo universiteta

Pashentseva A.V.

Samara State Medical University, Ministry of Health of Russia, Samara, Russia

Sharonova L.A.

Samara State Medical University, Health Ministry of Russia, Samara, Russia

Close metadata

References:

  1. Kanis JA. Оn behalf of the World Health Organization Scientific Group (2007). Assessment of osteoporosis at the primary health-care level. Technical Report. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK. 2007: Printed by University of Sheffield.
  2. Bolotnova TV, Platitsyna NG, Kuslivaya ON. Osteoporosis in patients with ischemic heart disease and arterial hypertension. Vrach. 2014;2:2-4. (In Russ.)
  3. Karpova NYu, Shostak NA, Rashid MA, Sorokoletov SM, Kazakova TV. The case of spine osteoporosis at the man with calcinated aortal stenosis at advanced age. Klinitsist. 2013;1:55-60. (In Russ.)
  4. Platitsyna NG, Kuslivaya ON, Bolotnova TV. Osteoporois and cardiovascular patology: risk factors, clinic-functional features. Profilakticheskaya i klinicheskaya meditsina. 2013;4(49):59-63. (In Russ.)
  5. Citron JT, Ettinger B, Genant HK. Spinal bone mineral loss in estrogen-repleted, calcium-repleted premenopausal women. Osteoporosis Int. 2005;5:228-233. doi:10.1007/bf01774011
  6. Fomina LA, Zyabreva IA. Epidemiological aspects of osteoporosis and osteopenia. Verkhnevolzhskii Meditsinskii Zhurnal. 2014;4:21-25. (In Russ.)
  7. Lesnyak OM, Benevolenskaya LI. Osteoporosis in the Russian Federation: Problems and Perspectives. Nauchno-prakticheskaya revmatologiya. 2010;5:14-18. (In Russ.) doi:10.14412/1995-4484-2010-725
  8. Bashkova IB, Madyanov IV, Kazankov YuV. Rasprostranennost' osteoporoza i osteopenii v populyatsionnoi vyborke zhitelei nekotorykh gorodov Volgo-Vyatskogo raiona Privolzhskogo Federal'nogo okruga (po dannym osteodensitometricheskogo issledovaniya). Zdravookhranenie Chuvashii. 2009;4:28-36. (In Russ.)
  9. Bulgakova SV. Epidemiology of low mineral dencity of bone tissue in Samara. V sbornike: Klinicheskie i fundamental'nye aspekty gerontologii Sbornik nauchnykh trudov. pod redaktsiei GP Kotel'nikova, NO Zakharovoi. Samara; 2015:55-58. (In Russ.)
  10. Lesnyak OM. Audit condition of a problem of osteoporosis in Eastern Europe and Central Asia countries 2010. Osteoporoz i osteopatii. 2011;2:3-6. (In Russ.)
  11. Lesnyak OM, Ershova OB, Belova KYu i dr. Epidemiology of fracture in the Russian Federation and the development of a FRAX model. Osteoporoz i osteopatii. 2014;3:3-8. (In Russ.) doi:10.1007/s11657-012-0082-3
  12. Dreval' AV, Marchenkova LA, Grigor'eva EA. The estimatin of the quality of diagnostiс of post-menopausal osteoporosis in the Moskow region from the results of a questionnaire study. Problemy endokrinologii. 2012;1(58):23-28. (In Russ.) doi:10.14341/probl201258123-28
  13. Ametov AS. Izbrannye lektsii po endokrinologii. M.: OOO «Meditsinskoe informatsionnoe agentstvo»; 2012. (In Russ.)
  14. Ershova OB, Belova KYu, Nazarova AV, Novikova IV. Risk factors of osteoporosis and fractures. Osteoporoz i osteopatii. 2009;1:33-38. (In Russ.)
  15. Esedova AE, Idrisova MA, Makhtibekova PA, Velikhanova AV, Taibova DU. Osteopenical changes in postmenopausal women against obesity. Vrach-aspirant. 2016;1:95-100. (In Russ.)
  16. Zakharov IS, Kolpinskii GI, Ushakova GA i dr. Prevalence of osteopenic syndrome in postmenopausal women. Medtsina v Kuzbasse. 2014;3:32-36. (In Russ.)
  17. Verbovoi AF, Tseitlin OYa. Rasprostranennost', diagnostika, profilaktika osteoporoza. Metodicheskoe posobie. Samara; 2002. (In Russ.)
  18. Klinicheskie rekomendacii po profilaktike i vedeniju bol'nyh s osteoporozom. Izdanie 2-e, dopolnennoe/pod redakciej prof. OM Lesnjak. Rossijskaja associacija po osteoporozu. Jaroslavl': IPK «Lite-ra»; 2014. (In Russ.)
  19. Krivtsunov A, Zlobina I, Pavlova I. Osteoporosis and osteoartrosis at advanced and senile age. Vrach. 2014;6:6-9. (In Russ.)
  20. Institute for Clinical Systems Improvement (ICSI) Health Care Guideline: Diagnosis and Treatment of Osteoporosis, 5th edition, July 2006.
  21. Kanis JA et al. A family history of fracture and fracture risk: a metaanalisys. Bone. 2004;35(5):1029-1037. doi:10.1016/j.bone.2004.06.017
  22. Savel'eva KA, Kotova SM, Oreshko LS, Koloskov VA. Osteoporois as a problem of general medical practice. Profilakticheskaya i klinicheskaya meditsina. 2011;4(41):106-109. (In Russ.)
  23. Doskina EV. Diabetes mellitus and osteoporosis. Analysis of the combined approach to treatment. Farmateka. 2014;10:30-33. (In Russ.)
  24. Schwartz AV, Sellmeyer DE. Diabetes, fracture, and bone fragility. Curr Osteoporos Rep. 2007;5(3):105-111. doi:10.1007/s11914-007-0025-x
  25. Hofbauer LC, Brueck CC, Singh SK, Dobnig H. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res. 2007;22:1317-1328. doi:10.1359/jbmr.070510
  26. Obadina EL, Simonova OV, Chicherina EN. Clinical value of an assessment of 10-years risk of fractures in diagnostics of osteoporois in patients with rheumatoid arthritis. Vyatskii meditsinskii vestnik. 2015;1(45):17-20. (In Russ.)
  27. Men'shikova IV. Secondary osteoporois at rheumatic diseases. Farmateka. 2014;10(2):34-39. (In Russ.)
  28. Muradyants AA, Shostak NA, Kondrashov AA. Osteoporois in male patient with reumatoid arthritis (clinical surveillance). Klinitsist. 2014;1:71-76. (In Russ.)
  29. Verbovoi AF. Bone tissue in patients with vibration disease. Gigiena i sanitarija. 2004;4:35-37.
  30. Verbovoj AF, Kosarev VV, Cejtlin OJa. Assessment of a condition of bone tissue by method of ultrasonic densitometry in patients with vibration disease. Osteoporoz i osteopatii. 1998;2:16-17. (In Russ.)
  31. Verbovoi AF. Results of spine X-ray morphometry and ultrasonic densitometry in patients with vibration disease. Osteoporoz i osteopatii. 2001;2:16. (In Russ.)
  32. Avcyn AP, Zhavoronkov AA. Patologija fljuoroza. Novosibirsk: Nauka; 1981. (In Russ.)
  33. Verbovoi AF. State of bone tissue and calcium-phosphorus metabolism in workers of phosphorus industry. Kazanskii medits. zhurnal. 2002;83(2);147-150. (In Russ.)
  34. Siminoski K, Jiang G, Adachi JD et al. Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures. Osteoporos. Int. 2005;16(4):403-410. doi:10.1007/s00198-004-1709-z
  35. Pigarova EA, Rozhinskaya LYa. Modern approaches to diagnostics and treatment of osteoporosis. Consilium Medicum. 2014;16(4):82-87. (In Russ.)
  36. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4(6):368-381. doi:10.1007/bf01622200
  37. Zakharov IS. Radial diagnostics of osteoporosis — current state of the problem. Politravma. 2015;1:69-73. (In Russ.)
  38. Chernova TO. Visualization and quantitative analysis at osteoporosis and an osteomalyation. Meditsinskaya vizualizatsiya. 2005;1:111-121. (In Russ.)
  39. Dobnig H, Sipos A, Jiang Y et al. Early changes in biochemical markers of bone formation coopelate with improvements in bone structure during teriparatide therapy. J Clin Endocrinol Metab. 2005;90(7):3970-3977.
  40. Greenspan SL, Resnick NM, Parker RA. Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: a three-year, double-blind, placebo-controlled, randomized clinical trial. J Clin Endocrinol Metab. 2005;90(5):2762-2767.
  41. Safonova YuA, Zotkin EG, Kosul'nikova EN. Falls as geriatric syndrome and methods of their prevention. Farmateka. 2014;10:40-43. (In Russ.)
  42. Damulin IV. Falls between persons of advanced and senile age. Farmateka. 2013;10:18-24. (In Russ.)
  43. Wells GA, Cranney A, Peterson J et al. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev. 2008;23(1):CD001155. doi:10.1002/14651858.cd001155.pub2
  44. Miller PD, McClung MR, Macovei L et al. Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study. J. Bone Miner. Res. 2005;20(8):1315-1322.
  45. Bianchi G, Czerwinski E, Kenwright A et al. Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension. Osteoporos Int. 2012;23(6):1769-1778. doi:10.1007/s00198-011-1793-9
  46. Black DM, Delmas PD, Eastell R et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356(18):1809-1822. doi:10.1056/nejmoa067312
  47. Black DM, Reid IR, Cauley JA et al. The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res. 2015;30(5):934-944. doi:10.1002/jbmr.2442
  48. Neer RM, Arnaud CD, et al. Effect of parathyroid hormone (1—34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344:1434-1441. doi:10.1056/nejm200105103441904
  49. Cummings SR, San Martin J, McClung MR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361:756-765. doi:10.1056/nejmx090058
  50. Reginster JY, Seeman E, De Vernejoul MC et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis treatment of peripheral osteoporosis (TROPOS) study. J Clinical Endocrinology and Metabolism. 2005;90:2816-2822. doi:10.1210/jc.2004-1774
  51. European Medicines Agency (2012) Questions and answers on the review of Protelos and Osseor (strontium ranelate). http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2012/03/WC500124208.pdf
  52. Boonen S, Lips P, Bouillon R et al. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J. Clinical Endocrinology & Metabol. 2007;92(4):1415-1423. doi:10.1210/jc.2006-1404
  53. Devine A, Prince RL, Dhalival SS et al. Results of a 5 Year Double Blinde, Placebo Controlled Trial of Calcium Supplementation (CAIFOS): Bone Density Outcomes. J Bone Miner Res. 2004;SA416.
  54. Doskina EV, Doskin AV. Pain and its features at osteoporosis. Farmateka. 2012;3:63-66. (In Russ.)
  55. European Medicines Agency (2012) Questions and answers on the review of calcitonin-containing medicine. EMEA, http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Calcitonin_31/WC500130149.pdf
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.